i10 Productivity
Rankings
Eli Lilly and Company Scientists i10 Productivity Rankings 2025
Productivity Rankings is an exclusive service provided by AD Scientific Index. This ranking system, derived from the i10 index, highlights the productivity of scientists in publishing impactful scientific articles. Productivity Rankings serves as a tool to identify highly productive scientists across specific areas, disciplines, universities, and countries, and supports the creation of effective incentives and academic policies. The global, regional, and institutional rankings of scientists in this table are calculated based on their total i10 index. Moreover, you can explore special rankings derived from Productivity Rankings, such as Scientists Last 6 Years' i10 Index, Universities Total i10 Index Rankings 2025, Universities Last 6 Years' i10 Index Rankings 2025, Art and Humanities i10 Productivity Rankings, and Social Sciences and Humanities i10 Productivity Rankings.
* Total i10 IndexRankings
Ranking Based On Selection :1
psychosis
neurodegeneration
bioinformatics
genomics
drug development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
447
264
0.591
* Total i10 IndexRankings
Ranking Based On Selection :2
Immuno-Oncology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
215
113
0.526
* Total i10 IndexRankings
Ranking Based On Selection :3
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
207
191
0.923
* Total i10 IndexRankings
Ranking Based On Selection :4
PBPK Models
DDI
CYPs
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
176
106
0.602
* Total i10 IndexRankings
Ranking Based On Selection :5
GI cancer
translational research
lung cancer
phase 1 trials
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
175
86
0.491
* Total i10 IndexRankings
Ranking Based On Selection :6
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
148
76
0.514
* Total i10 IndexRankings
Ranking Based On Selection :7
Neuroscience & Drug Discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
89
0.622
* Total i10 IndexRankings
Ranking Based On Selection :8
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
140
35
0.250
* Total i10 IndexRankings
Ranking Based On Selection :9
Neurodegeneration
Neuroscience
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
135
79
0.585
* Total i10 IndexRankings
Ranking Based On Selection :10
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
112
42
0.375
* Total i10 IndexRankings
Ranking Based On Selection :11
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
88
0.838
* Total i10 IndexRankings
Ranking Based On Selection :12
Clinical research
patients
methodology
effectiveness
cost-effectiveness
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
41
0.390
* Total i10 IndexRankings
Ranking Based On Selection :13
Osteoporosis
Migraine
Cardiovascular Disease
Drug Development
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
76
0.768
* Total i10 IndexRankings
Ranking Based On Selection :14
diabetes
cardiovascular diseases
osteoporosis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
88
53
0.602
* Total i10 IndexRankings
Ranking Based On Selection :15
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
88
51
0.580
* Total i10 IndexRankings
Ranking Based On Selection :16
Alzheimer's disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
80
0.964
* Total i10 IndexRankings
Ranking Based On Selection :17
Alzheimer's disease
Neurodegeneration
Drug discovery
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
82
62
0.756
* Total i10 IndexRankings
Ranking Based On Selection :18
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
81
53
0.654
* Total i10 IndexRankings
Ranking Based On Selection :19
Diabetes
endocrinology
fatty liver disease
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
76
41
0.539
* Total i10 IndexRankings
Ranking Based On Selection :20
Lipoprotein Metabolism and Atherosclerosis
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
75
47
0.627
* Total i10 IndexRankings
Ranking Based On Selection :21
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
74
58
0.784
* Total i10 IndexRankings
Ranking Based On Selection :22
Computational chemistry
molecular modeling
biophysics
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
73
23
0.315
* Total i10 IndexRankings
Ranking Based On Selection :23
psychopharmamcology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
73
42
0.575
* Total i10 IndexRankings
Ranking Based On Selection :24
Health outcomes
pediatrics
epidemiology
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
69
43
0.623
* Total i10 IndexRankings
Ranking Based On Selection :25
Diabetes
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
68
35
0.515
David A Collier
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
447
264
0.591
psychosis
neurodegeneration
bioinformatics
genomics
drug development
Prachi Sharma
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
215
113
0.526
Jiye Shi
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
207
191
0.923
Drug Discovery
Informatics
Computational Chemistry
Biophysics
Nanotechnology
Stephen Hall
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
176
106
0.602
David R Ferry
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
175
86
0.491
Tony Zhang
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
148
76
0.514
process chemistry
organic chemistry. pharmaceutical
green chemistry
catalysis
Christian C Felder
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
143
89
0.622
Neuroscience & Drug Discovery
Jonathan A Lee
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
140
35
0.250
Michael O'Neill
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
135
79
0.585
Bob Campbell
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
112
42
0.375
oncology/I-O/autoimmune diseases
drug discovery
kinases
epigenetics
RNA modulation
Eswar Krishnan
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
88
0.838
José Antonio Sacristán
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
105
41
0.390
Clinical research
patients
methodology
effectiveness
cost-effectiveness
JH Krege
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
99
76
0.768
Imre Pavo
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
88
53
0.602
David H Adams
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
88
51
0.580
Stéphane Epelbaum
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
83
80
0.964
Martin Citron
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
82
62
0.756
Francis Willard
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
81
53
0.654
Drug Discovery
G-proteins
GPCRs
Receptors
Pharmacology
Mark L Hartman
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
76
41
0.539
Diabetes
endocrinology
fatty liver disease
Giacomo Ruotolo
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
75
47
0.627
Scot J Matkovich
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
74
58
0.784
Heart disease
inflammation
diabetes
noncoding RNAs
systems biology
Howard Broughton
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
73
23
0.315
Computational chemistry
molecular modeling
biophysics
Joel Raskin
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
73
42
0.575
Joe Johnston
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
69
43
0.623
Health outcomes
pediatrics
epidemiology
Zvonko Milicevic
Eli Lilly and Company
Indianapolis, United States
i-10 Metrics
Total
Last 6 Years
Last 6 Years / Total
68
35
0.515